Comparable stake leader
Legion Partners Asset Management, LLC
SEC ownership of LIFECORE BIOMEDICAL, INC. \DE\
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001005286.
Disclosed value leader
Legion Partners Asset Management, LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- LFCR on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Legion Partners Asset Management, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Legion Partners Asset Management, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001005286
- Issuer location
- Chaska, MN
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of LIFECORE BIOMEDICAL, INC. \DE\ (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Legion Partners Asset Man...
Disclosed value leader
Legion Partners Asset Man...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 17%
13D/G row: Legion Partners Asset Management, LLC
Showing 1-8 of 50 holder rows.
Quick read
Legion Partners Asset Management, LLC leads the comparable SEC ownership view at 17%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Legion Partners Asset Management, LLC's linked filing trail.
Comparable ownership
Top 5
Legion Partners Asset Management,...
17%
Greenhaven Road Investment Manage...
9.8%
22NW Fund, LP
6.7%
BlackRock, Inc.
5.4%
David Capital Partners, LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC |
13D/G
3/4/5
13F
Legion Partners Holdings, LLC · Director, 10%+ Owner · Company
|
17%
|
$38,253,570
6,794,595 shares
|
$0 | 30 Jun 2026 |
| Greenhaven Road Investment Management, L.P. |
13D/G
13F
Company
|
9.8%
|
$22,998,689
3,616,146 shares
|
+$7,944,848 | 31 Dec 2024 |
| 22NW Fund, LP |
13D/G
|
6.7%
|
$15,271,217
2,712,472 shares
|
-$1,480,273 | 30 Jun 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.4%
|
$10,555,366
2,010,546 shares
|
+$748,808 | 30 Jun 2026 |
| David Capital Partners, LLC |
13D/G
|
4.9%
|
$11,467,080
1,803,000 shares
|
$0 | 31 Dec 2024 |
| Christopher S. Kiper |
3/4/5
Director, 10%+ Owner
|
12%
|
$16,766,916
4,507,236 shares
|
— | 04 Jun 2026 |
| Legion Partners Holdings, LLC |
3/4/5
Director, 10%+ Owner
|
12%
|
$16,766,916
4,507,236 shares
|
— | 04 Jun 2026 |
| Legion Partners, L.P. I |
3/4/5
Director, 10%+ Owner
|
12%
|
$16,766,916
4,507,236 shares
|
— | 04 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 32 reporting-owner rows connected to LIFECORE BIOMEDICAL, INC. \DE\. Open a relationship link for the CIK-to-CIK filing trail.
Rows
32
Largest Forms 3/4/5 holder
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Net 12M change
$0
Latest report
04 Jun 2026
Recent insider transactions for LIFECORE BIOMEDICAL, INC. \DE\
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher S. Kiper | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Kiper Christopher S | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Kiper Christopher S | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Kiper Christopher S | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Kiper Christopher S | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Kiper Christopher S | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Christopher S. Kiper | LFCR | Common Stock | Award | 33.4% | 25,907 | 103,482 | 04 Jun 2026 | Direct | ||
| Nelson Obus | LFCR | Common Stock | Award | 18.8% | 25,907 | 164,100 | 04 Jun 2026 | Direct | ||
| Jason Aryeh | LFCR | Common Stock | Award | 58.8% | 25,907 | 69,967 | 04 Jun 2026 | Direct | ||
| Joshua Schechter | LFCR | Common Stock | Award | 24.2% | 25,907 | 133,080 | 04 Jun 2026 | Direct | ||
| Matthew E. Korenberg | LFCR | Common Stock | Award | 58.8% | 25,907 | 69,967 | 04 Jun 2026 | Direct | ||
| Humberto C. Antunes | LFCR | Common Stock | Award | 55% | 25,907 | 72,967 | 04 Jun 2026 | Direct | ||
| Paul H. Johnson | LFCR | Common Stock | Award | 58.8% | 25,907 | 69,967 | 04 Jun 2026 | Direct | ||
| Katrina Houde Lovas | LFCR | Common Stock | Award | 23.7% | 25,907 | 135,319 | 04 Jun 2026 | Direct | ||
| Paul Josephs | LFCR | Common Stock | Tax liability | -6.38% | -40,413 | 592,915 | 20 May 2026 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Tax liability | -9.09% | -24,645 | 246,333 | 14 Apr 2026 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Award | 12.4% | 30,000 | 270,978 | 02 Mar 2026 | Direct | ||
| Ryan David Lake | LFCR | Common Stock | Tax liability | -6.38% | -22,932 | 336,691 | 03 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.